GANX
Gain Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
No N-PORT holders.
—
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
Gain Therapeutics, Inc.
1.14
Largest filed tie
—
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Marshall WaceMarshall Wace | $3.9M | 20.51% | +8.69% | |
| 2 | Cambridge Investment Research AdvisorsCambridge Investment Research | $2.3M | 12.13% | +100.00% | |
| 3 | Potomac Capital ManagementPotomac | $1.9M | 10.09% | −6.17% | |
| 4 | GSA Capital PartnersGSA Capital Partners | $1.3M | 6.74% | +102.30% | |
| 5 | Jones Financial Companies LllpJones Financial Companies Lllp | $1.2M | 6.49% | −3.65% | |
| 6 | DME Capital ManagementDME | $1.1M | 6.04% | 0.00% | |
| 7 | Vanguard Capital ManagementVanguardindex-like | $974,946 | 5.12% | +20.10% | |
| 8 | Geode Capital ManagementGeodeindex-like | $921,372 | 4.84% | +1.38% | |
| 9 | BlackRockBlackRockindex-like | $558,163 | 2.93% | +22.18% | |
| 10 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $470,014 | 2.47% | +0.68% | |
| 11 | UBS GroupUBS | $436,475 | 2.29% | −2.48% | |
| 12 | Stratos Wealth PartnersStratos Wealth Partners | $406,000 | 2.13% | +51.95% | |
| 13 | Citadel AdvisorsCitadel | $396,305 | 2.08% | +175.74% | |
| 14 | Cresset Asset ManagementCresset | $324,800 | 1.71% | 0.00% | |
| 15 | State StreetState Streetindex-like | $319,800 | 1.68% | 0.00% | |
| 16 | Susquehanna International GroupSusquehanna International | $289,896 | 1.52% | −69.59% | |
| 17 | Squarepoint OpsSquarepoint Ops | $276,809 | 1.45% | new | |
| 18 | Morgan StanleyMorgan Stanley | $255,723 | 1.34% | −9.80% | |
| 19 | LPL FinancialLPL Financial | $238,020 | 1.25% | +12.47% | |
| 20 | Jane Street GroupJane Street | $197,373 | 1.04% | −61.94% | |
| 21 | Northern TrustNorthern Trustindex-like | $196,936 | 1.03% | −14.90% | |
| 22 | Commonwealth Equity ServicesCommonwealth Equity Services | $118,670 | 0.62% | +96.80% | |
| 23 | XTX TopcoXTX Topco | $112,247 | 0.59% | new | |
| 24 | Springbok Capital ManagementSpringbok | $72,715 | 0.38% | 0.00% | |
| 25 | Benedict Financial AdvisorsBenedict Financial | $71,050 | 0.37% | +125.81% |
50 managers report $19.0M of Gain Therapeutics on form 13F for the quarter ended Jun 30 '26. 12 of them hold 80% of it; Marshall Wace is largest at 20.51%.
Expected move
No implied move.